Finvector Vision Therapies
Pre-clinicalA leading cGMP manufacturer of viral-based products with a strong commitment to restoring hope, purpose and a true sense of belonging for those living with chronic health conditions.
Founded
2014
Focus
OphthalmologyGene Therapy
About
A leading cGMP manufacturer of viral-based products with a strong commitment to restoring hope, purpose and a true sense of belonging for those living with chronic health conditions.
Funding History
1Total raised: $15M
Series A$15MKurma PartnersMay 15, 2021
Company Info
TypePrivate
Founded2014
LocationKuopio, Finland
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
3PBIOVIAN
Pre-clinical · Turku
Faron Pharmaceuticals
Phase 1/2 · Turku
Bone Index
Pre-clinical · Kuopio
Genomill Health
Pre-clinical · Helsinki
GlucoModicum
Pre-clinical · Helsinki
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile